BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25742479)

  • 21. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Am J Epidemiol; 2002 Aug; 156(4):363-73. PubMed ID: 12181107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group.
    John EM; Whittemore AS; Harris R; Itnyre J
    J Natl Cancer Inst; 1993 Jan; 85(2):142-7. PubMed ID: 8418303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological factors and prophylaxis of ovarian tumors.
    Bettochi S; Restaino A; Lucisano F; Orlando E; Ferreri R; Ierardi GM; Selvaggi L
    Eur J Gynaecol Oncol; 1982; 3(3):192-205. PubMed ID: 6762965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics relating to ovarian cancer risk: implications for prevention and detection.
    Whittemore AS
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S15-9. PubMed ID: 7835800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.
    Franceschi S; Parazzini F; Negri E; Booth M; La Vecchia C; Beral V; Tzonou A; Trichopoulos D
    Int J Cancer; 1991 Aug; 49(1):61-5. PubMed ID: 1874572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical activity and risk of endometrial cancer: the European prospective investigation into cancer and nutrition.
    Friedenreich C; Cust A; Lahmann PH; Steindorf K; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S; Linseisen J; Rohrmann S; Pischon T; Schulz M; Tjønneland A; Johnsen NF; Overvad K; Mendez M; Arguelles MV; Garcia CM; Larrañaga N; Chirlaque MD; Ardanaz E; Bingham S; Khaw KT; Allen N; Key T; Trichopoulou A; Dilis V; Trichopoulos D; Pala V; Palli D; Tumino R; Panico S; Vineis P; Bueno-de-Mesquita HB; Peeters PH; Monninkhof E; Berglund G; Manjer J; Slimani N; Ferrari P; Kaaks R; Riboli E
    Int J Cancer; 2007 Jul; 121(2):347-55. PubMed ID: 17357139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
    Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
    Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
    Mavaddat N; Peock S; Frost D; Ellis S; Platte R; Fineberg E; Evans DG; Izatt L; Eeles RA; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Brewer C; Tischkowitz M; Douglas F; Hodgson S; Walker L; Porteous ME; Morrison PJ; Side LE; Kennedy MJ; Houghton C; Donaldson A; Rogers MT; Dorkins H; Miedzybrodzka Z; Gregory H; Eason J; Barwell J; McCann E; Murray A; Antoniou AC; Easton DF;
    J Natl Cancer Inst; 2013 Jun; 105(11):812-22. PubMed ID: 23628597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
    Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM
    Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of ovarian cancer in Greece: a case-control study.
    Tzonou A; Day NE; Trichopoulos D; Walker A; Saliaraki M; Papapostolou M; Polychronopoulou A
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1045-52. PubMed ID: 6540687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.
    Negri E; Tzonou A; Beral V; Lagiou P; Trichopoulos D; Parazzini F; Franceschi S; Booth M; La Vecchia C
    Int J Cancer; 1999 Mar; 80(6):848-51. PubMed ID: 10074916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women.
    McGuire V; Hartge P; Liao LM; Sinha R; Bernstein L; Canchola AJ; Anderson GL; Stefanick ML; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1059-63. PubMed ID: 27197274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for epithelial ovarian cancer in Beijing, China.
    Chen Y; Wu PC; Lang JH; Ge WJ; Hartge P; Brinton LA
    Int J Epidemiol; 1992 Feb; 21(1):23-9. PubMed ID: 1544753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
    Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
    BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin, other NSAIDs, and ovarian cancer risk (United States).
    Fairfield KM; Hunter DJ; Fuchs CS; Colditz GA; Hankinson SE
    Cancer Causes Control; 2002 Aug; 13(6):535-42. PubMed ID: 12195643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age at natural menopause and the risk of epithelial ovarian cancer.
    Schildkraut JM; Cooper GS; Halabi S; Calingaert B; Hartge P; Whittemore AS
    Obstet Gynecol; 2001 Jul; 98(1):85-90. PubMed ID: 11430962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical models of ovarian cancer incidence.
    Rosner BA; Colditz GA; Webb PM; Hankinson SE
    Epidemiology; 2005 Jul; 16(4):508-15. PubMed ID: 15951669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.